ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
22
views
0
references
Top references
cited by
121
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,127
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The discovery and development of HMG-CoA reductase inhibitors.
Author(s):
Takaho Endo
Publication date:
1992-10-31
Journal:
Journal of Lipid Research
Keywords:
Animals
,
Anticholesteremic Agents
,
history
,
pharmacology
,
History, 20th Century
,
Humans
,
Hydroxymethylglutaryl-CoA Reductase Inhibitors
,
Hypercholesterolemia
,
drug therapy
,
Lovastatin
,
analogs & derivatives
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via crossref license)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Proceedings of the International Ocean Discovery Program
Author and article information
Journal
PubMed ID::
1464741
DOI::
10.1016/S0022-2275(20)41379-3
ScienceOpen disciplines:
Chemistry
Keywords:
Animals
,
Anticholesteremic Agents
,
history
,
pharmacology
,
History, 20th Century
,
Humans
,
Hydroxymethylglutaryl-CoA Reductase Inhibitors
,
Hypercholesterolemia
,
drug therapy
,
Lovastatin
,
analogs & derivatives
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Animals
,
Anticholesteremic Agents
,
history
,
pharmacology
,
History, 20th Century
,
Humans
,
Hydroxymethylglutaryl-CoA Reductase Inhibitors
,
Hypercholesterolemia
,
drug therapy
,
Lovastatin
,
analogs & derivatives
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,127
Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia.
Authors:
M Yoshizumi
,
Y Ouchi
,
Y Hirata
…
High mobility group protein-1 (HMG-1) is a unique activator of p53.
Authors:
T. E. G. K. Murthy
,
L. N. Moorthy
,
C Prives
…
From HMG through purified urinary FSH preparations to recombinant FSH: a substitution study.
Authors:
J E F Zwart-van Rijkom
,
F Broekmans
,
H. Leufkens
See all similar
Cited by
119
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
Authors:
Makoto Kinoshita
,
Koutaro Yokote
,
Hidenori Arai
…
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Authors:
Randall J. Bateman
,
Paul S Aisen
,
Bart De Strooper
…
Gut microbiota and cardiovascular disease: opportunities and challenges
Authors:
Negin Kazemian
,
Morteza Mahmoudi
,
Frank A Halperin
…
See all cited by